Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,636 | -35,709 | -26,606 | -17,659 | -8,491 |
| Depreciation Amortization | 125 | 638 | 421 | 220 | 108 |
| Accounts payable and accrued liabilities | 12 | 1 | -89 | 438 | -323 |
| Other Working Capital | -1,723 | 868 | -662 | 378 | 573 |
| Other Operating Activity | 919 | 3,130 | 2,343 | 1,102 | 1,026 |
| Operating Cash Flow | $-8,303 | $-31,072 | $-24,593 | $-15,521 | $-7,107 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | -562 | -206 | -98 | -3 |
| Investing Cash Flow | $-46 | $-562 | $-206 | $-98 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -4,739 | N/A | N/A | N/A |
| Common Stock Issued | 44 | 8,861 | 8,849 | 8,498 | 1,403 |
| Other Financing Activity | 0 | 7,281 | 7,280 | 7,281 | 0 |
| Financing Cash Flow | $44 | $11,403 | $16,129 | $15,779 | $1,403 |
| Beginning Cash Position | 31,598 | 51,829 | 51,829 | 51,829 | 51,829 |
| End Cash Position | 23,293 | 31,598 | 43,159 | 51,989 | 46,122 |
| Net Cash Flow | $-8,305 | $-20,231 | $-8,670 | $160 | $-5,707 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,303 | -31,072 | -24,593 | -15,521 | -7,107 |
| Capital Expenditure | -46 | -562 | -206 | -98 | -3 |
| Free Cash Flow | -8,349 | -31,634 | -24,799 | -15,619 | -7,110 |